2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow ESRD: new trials by email Literature Review of ESRD trials Research Report on ESRD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis Canagliflozin 300 MG - ESRD, CKD (Chronic Kidney Disease) Stage 5D | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2026-02-01 | 2026-03-16 |
| Adding Urea to the Final Dialysis Fluid Urea in the dialysate - Dysequilibrium Syndrome, ESRD | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 20 | 2025-09-16 | 2026-02-12 |
Kidney Failure, Chronic (2) · Acidosis (1) · Dysequilibrium syndrome (1) · Hyperkalemia (1) · Peritoneal Fibrosis (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Acid-Base Imbalance (1) · Digestive System Diseases (1) · Fibrosis (1) · Metabolic Diseases (1)
Canagliflozin (1) · Urea (1)
McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · University of California, San Francisco (1)
Canada (1) · United States (1)
Ramin Sam, MD (1) · Thomas A. Mavrakanas, MD, MSc. (1)
2025 (1)